Private Equity

With veteran CEO Jim Kircher at the helm, Sigmatron enters a new era under private equity owner Transom Capital, poised for aggressive growth and operational overhaul.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

As Dubai's property market matures, IPS 2026 emerges as more than a showcase, creating a vital ecosystem where global capital meets next-gen urban innovation.

FS Specialty Lending Fund's high dividend is tempting, but a steep market price drop and a large discount to NAV reveal a complex story for income seekers.

Steward Partners lands its largest-ever wirehouse breakaway, as the $2.4B Zelniker Dorfman team joins, highlighting a major shift in wealth management.

A new initiative by Snowflake, ExecAtlas, and industry peers aims to create a universal language for financial data, paving the way for trusted, autonomous AI.

Capsa Healthcare's acquisition of The Harloff Company isn't just another merger; it's a strategic play to build an end-to-end healthcare solutions empire.

Cliffwater's hire of Sean Brenan and launch of its Cascade Real Assets Fund is a calculated move to exploit market turmoil and democratize access to private assets.

As millions of owners face retirement, a new firm is offering an alternative to the PE playbook of quick flips, promising to hold businesses forever. Is this the future?

A tectonic shift is underway in how we get paid. Driven by AI and new laws, compensation is moving from a back-office task to a strategic business driver.

With its third North American acquisition in two years, Axiom GRC isn't just buying a firm—it's buying a strategic foothold in the future of AI governance.

Nixxy Inc.'s radical pivot to a 1GW energy-first AI platform with Tachyon9 highlights a new industry truth: the AI race is now a power race.

Alchelyst and Allfunds are using blockchain to fix the broken back office of private markets. This is the story behind the numbers and what it means for growth.

Centre Street Partners launches Accretus, an AI-driven platform to modernize the $100B 1031 exchange market after acquiring a trusted regional leader.

Brookwood, a real estate PE firm, did the unthinkable: it built a retail giant from scratch. The successful Nasdaq IPO of Yesway is more than a win; it's a new playbook.

With a novel 'gastric bypass in a pill' and a new CFO known for orchestrating lucrative exits, Syntis Bio is gearing up for a high-stakes battle in the booming obesity drug market.

The acquisition of Pathway Capital creates a $185B giant, signaling a new phase of consolidation where scale is king and private markets open to new money.

ACORE CAPITAL's hire of a top marketing veteran isn't just a new title. It's a strategic play in a world where private credit giants must now win hearts and minds, not just deals.

New research reveals Indigenous-led projects are not just a social good, but a critical economic engine for Canada's energy transition and resource economy.

New data on elecoglipron, an oral pill with no food restrictions, shows major weight loss and A1C reduction, positioning AstraZeneca to disrupt the GLP-1 market.